Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (2,480,823)	$ (2,611,835)
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation	210,797	211,900
Changes in operating assets and liabilities:
Prepaid expenses	(104,558)	429,292
Accounts payable	31,404	(106,282)
Accrued expenses	(383,645)	43,003
Net cash used in operating activities	(2,726,825)	(2,033,922)
Cash flows from financing activities:
Proceeds from issuance of common stock		6,646,748
Proceeds from issuance of common stock upon exercise of options		52,400
Net cash provided by financing activities		6,699,148
Net (decrease) increase in cash and cash equivalents	(2,726,825)	4,665,226
Cash and cash equivalents, beginning of period	11,247,403	14,548,471
Cash and cash equivalents, end of the period	8,520,578	19,213,697
Supplemental Disclosure of Noncash Investing and Financing Activities:
Offering costs included in accounts payable		$ 248,927